BR9708609A - Derivado de ácido carboxilico e usos de compostos e de uma combinação de composto - Google Patents
Derivado de ácido carboxilico e usos de compostos e de uma combinação de compostoInfo
- Publication number
- BR9708609A BR9708609A BR9708609A BR9708609A BR9708609A BR 9708609 A BR9708609 A BR 9708609A BR 9708609 A BR9708609 A BR 9708609A BR 9708609 A BR9708609 A BR 9708609A BR 9708609 A BR9708609 A BR 9708609A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- carboxylic acid
- acid derivative
- compound combination
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19614534A DE19614534A1 (de) | 1996-04-12 | 1996-04-12 | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
| PCT/EP1997/001684 WO1997038980A1 (de) | 1996-04-12 | 1997-04-04 | Neue carbonsäurederivate, ihre herstellung und verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9708609A true BR9708609A (pt) | 1999-08-03 |
Family
ID=7791118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9708609A BR9708609A (pt) | 1996-04-12 | 1997-04-04 | Derivado de ácido carboxilico e usos de compostos e de uma combinação de composto |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6610691B1 (pt) |
| EP (1) | EP0892786B1 (pt) |
| JP (1) | JP2000508324A (pt) |
| KR (1) | KR20000005367A (pt) |
| CN (1) | CN1216041A (pt) |
| AR (1) | AR006616A1 (pt) |
| AT (1) | ATE268760T1 (pt) |
| AU (1) | AU714717B2 (pt) |
| BG (1) | BG63201B1 (pt) |
| BR (1) | BR9708609A (pt) |
| CA (1) | CA2251381A1 (pt) |
| CO (1) | CO4900039A1 (pt) |
| CZ (1) | CZ324798A3 (pt) |
| DE (2) | DE19614534A1 (pt) |
| HR (1) | HRP970199A2 (pt) |
| HU (1) | HUP9901315A3 (pt) |
| ID (1) | ID16824A (pt) |
| IL (1) | IL126027A0 (pt) |
| NO (1) | NO311571B1 (pt) |
| NZ (1) | NZ331735A (pt) |
| PL (1) | PL329238A1 (pt) |
| SK (1) | SK133998A3 (pt) |
| TR (1) | TR199802044T2 (pt) |
| TW (1) | TW426672B (pt) |
| WO (1) | WO1997038980A1 (pt) |
| ZA (1) | ZA973098B (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL130251A0 (en) * | 1996-12-18 | 2000-06-01 | Basf Ag | Heterocyclic carboxylic acid derivatives the production and use thereof as endothelin receptor antagonists |
| US6030975A (en) * | 1997-03-14 | 2000-02-29 | Basf Aktiengesellschaft | Carboxylic acid derivatives, their preparation and use in treating cancer |
| EP1027338A2 (de) * | 1997-10-31 | 2000-08-16 | Basf Aktiengesellschaft | Neue carbonsäurederivate, die amidseitenketten tragen, ihre herstellung und verwendung als endothelin-rezeptorantagonisten |
| DE19806438A1 (de) * | 1998-02-17 | 1999-08-19 | Basf Ag | Neue Carbonsäurederivate mit 5-substituiertem Pyrimidinring, ihre Herstellung und Verwendung |
| US7566452B1 (en) | 1999-05-04 | 2009-07-28 | New York University | Cancer treatment with endothelin receptor antagonists |
| DE10025728A1 (de) * | 2000-05-25 | 2001-11-29 | Basf Ag | Neue Carbamate und Harnstoffe, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten |
| WO2002064573A1 (de) * | 2001-02-14 | 2002-08-22 | Abbott Gmbh & Co. Kg | Neue carbonsäurederivate mit alkylsubstituierten triazinen, ihre herstellung und verwendung als endothelin-rezeptorantagonisten |
| DK1243262T3 (da) | 2001-03-20 | 2006-10-02 | Sanol Arznei Schwarz Gmbh | Hidtil ukendt anvendelse af en peptidklasse af forbindelser til behandling af ikke-neuropatiske, inflammatoriske smerter |
| EP1243263B1 (en) | 2001-03-21 | 2002-11-27 | Schwarz Pharma Ag | Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain |
| US8008351B2 (en) | 2004-04-16 | 2011-08-30 | Ucb Pharma Gmbh | Methods for prophylaxis or treatment of conditions associated with cortical spreading depression |
| EP1604656A1 (en) | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Novel use of peptide compounds for treating amyotrophic lateral sclerosis (ALS) |
| ATE471717T1 (de) | 2004-08-27 | 2010-07-15 | Ucb Pharma Gmbh | Verwendung von peptidverbindungen zur behandlung von schmerzen durch knochenkrebs, chemotherapie- und nucleosid-bedingten schmerzen |
| JP2009502751A (ja) | 2005-07-22 | 2009-01-29 | メルク フロスト カナダ リミテツド | レニン阻害薬 |
| ES2450070T5 (es) | 2006-06-15 | 2018-05-08 | Ucb Pharma Gmbh | Composición farmacéutica que comprende lacosamida y levetiracetam con efecto anticonvulsionante sinérgico |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2053603A1 (en) * | 1990-10-19 | 1992-04-20 | Katsumasa Harada | 3-alkoxyalkanoic acid derivative, process for preparing the same and herbicide using the same |
| DE4313412A1 (de) | 1993-04-23 | 1994-10-27 | Basf Ag | 3-(Het)aryl-Carbonsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung |
| DE19533023B4 (de) * | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
-
1996
- 1996-04-12 DE DE19614534A patent/DE19614534A1/de not_active Withdrawn
-
1997
- 1997-04-04 CZ CZ983247A patent/CZ324798A3/cs unknown
- 1997-04-04 NZ NZ331735A patent/NZ331735A/en unknown
- 1997-04-04 DE DE59711704T patent/DE59711704D1/de not_active Expired - Fee Related
- 1997-04-04 BR BR9708609A patent/BR9708609A/pt not_active IP Right Cessation
- 1997-04-04 AT AT97915481T patent/ATE268760T1/de not_active IP Right Cessation
- 1997-04-04 WO PCT/EP1997/001684 patent/WO1997038980A1/de not_active Application Discontinuation
- 1997-04-04 JP JP9536697A patent/JP2000508324A/ja active Pending
- 1997-04-04 KR KR1019980708089A patent/KR20000005367A/ko not_active Application Discontinuation
- 1997-04-04 HU HU9901315A patent/HUP9901315A3/hu unknown
- 1997-04-04 SK SK1339-98A patent/SK133998A3/sk unknown
- 1997-04-04 US US09/155,946 patent/US6610691B1/en not_active Expired - Fee Related
- 1997-04-04 IL IL12602797A patent/IL126027A0/xx unknown
- 1997-04-04 CN CN97193749A patent/CN1216041A/zh active Pending
- 1997-04-04 EP EP97915481A patent/EP0892786B1/de not_active Expired - Lifetime
- 1997-04-04 CA CA002251381A patent/CA2251381A1/en not_active Abandoned
- 1997-04-04 AU AU22940/97A patent/AU714717B2/en not_active Ceased
- 1997-04-04 PL PL97329238A patent/PL329238A1/xx unknown
- 1997-04-04 TR TR1998/02044T patent/TR199802044T2/xx unknown
- 1997-04-11 ZA ZA973098A patent/ZA973098B/xx unknown
- 1997-04-11 TW TW086104677A patent/TW426672B/zh not_active IP Right Cessation
- 1997-04-11 AR ARP970101461A patent/AR006616A1/es unknown
- 1997-04-11 CO CO97018893A patent/CO4900039A1/es unknown
- 1997-04-11 HR HR19614534.1A patent/HRP970199A2/xx not_active Application Discontinuation
- 1997-04-14 ID IDP971241A patent/ID16824A/id unknown
-
1998
- 1998-10-05 BG BG102814A patent/BG63201B1/bg unknown
- 1998-10-09 NO NO19984714A patent/NO311571B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ331735A (en) | 2000-06-23 |
| EP0892786B1 (de) | 2004-06-09 |
| ATE268760T1 (de) | 2004-06-15 |
| TW426672B (en) | 2001-03-21 |
| CO4900039A1 (es) | 2000-03-27 |
| SK133998A3 (en) | 1999-03-12 |
| TR199802044T2 (xx) | 1999-02-22 |
| ZA973098B (en) | 1998-10-12 |
| DE19614534A1 (de) | 1997-10-16 |
| HRP970199A2 (en) | 1998-06-30 |
| ID16824A (id) | 1997-11-13 |
| NO311571B1 (no) | 2001-12-10 |
| AR006616A1 (es) | 1999-09-08 |
| DE59711704D1 (de) | 2004-07-15 |
| AU714717B2 (en) | 2000-01-06 |
| WO1997038980A1 (de) | 1997-10-23 |
| NO984714L (no) | 1998-10-09 |
| NO984714D0 (no) | 1998-10-09 |
| HUP9901315A3 (en) | 2000-03-28 |
| KR20000005367A (ko) | 2000-01-25 |
| IL126027A0 (en) | 1999-05-09 |
| PL329238A1 (en) | 1999-03-15 |
| US6610691B1 (en) | 2003-08-26 |
| CN1216041A (zh) | 1999-05-05 |
| BG102814A (en) | 1999-11-30 |
| JP2000508324A (ja) | 2000-07-04 |
| AU2294097A (en) | 1997-11-07 |
| HUP9901315A2 (hu) | 1999-08-30 |
| CZ324798A3 (cs) | 1999-04-14 |
| BG63201B1 (bg) | 2001-06-29 |
| EP0892786A1 (de) | 1999-01-27 |
| CA2251381A1 (en) | 1997-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9510256A (pt) | Derivados de ácido 3-aril-tetrônico | |
| HUP0105027A3 (en) | Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds and their use | |
| FI950910A (fi) | Rasvahappojohdannaiset | |
| NO924978L (no) | Chinolon- og naftyridon-karboksylsyrederivater | |
| PT892640E (pt) | Composicoes farmaceuticas de micofenolato entericamente revestidas | |
| BR9711223A (pt) | Derivados de cido arilsulfonilamino-hidrox mico | |
| DE69703385T2 (de) | Alkoxyessigsäure-derivate | |
| NO2011015I2 (no) | Paliperidon palmitatester | |
| BR9607492A (pt) | Conjugados de ácidos graxos de composto terapêutico | |
| NO994595L (no) | Salt av naftyridin-karboksylsyrederivat | |
| BR9708609A (pt) | Derivado de ácido carboxilico e usos de compostos e de uma combinação de composto | |
| DE59700915D1 (de) | Stabilisierter Milchsäurementhylester | |
| FI954007A (fi) | Substituoitujen 4-fenyyli-6-amino-nikotiinihappojohdannaisten käyttö lääkeaineena | |
| BR9708614A (pt) | Derivado de ácido carboxílico e utilização de um composto e de uma combinação de um composto | |
| NO921840D0 (no) | Substituerte karboksylsyrederivater | |
| NO923508D0 (no) | Bicykliske karboksylsyrederivater | |
| FI960634A (fi) | Uusia kinolonikarboksyylihappojohdannaisia | |
| IS5009A (is) | 3-Alkoxýísoxazól-4-ýl setin 2-amínó karboxýlsýru efnasambönd | |
| PL331263A1 (en) | Derivatives of glyoxylic acid | |
| IL115594A (en) | Preparation of alpha-tertiary carboxylic acid esters | |
| PL335601A1 (en) | Derivatives of 2-substituted benzoylcycloalkyl carboxylic acid | |
| DE59205221D1 (de) | 1-Alkoxyhexatrien-2-carbonsäureester | |
| BR9610139A (pt) | Derivado de ácido carboxílico | |
| ID20291A (id) | Asam-asam oksobutirat tersubstitusi sebagai penghamba-penghambat matriks metaloproteasa | |
| DE69707882T2 (de) | Carbonylierungsverfahren der pentensäuren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: ABBOTT GMBH AND CO. KG (DE) Free format text: TRANSFERIDO DE: BASF AKTIENGESELLSCHAFT |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 7A E 8A ANUIDADES. |